Mgbemena VE[Author] - Search Results

Year	Number of Results
2013	1
2014	2
2015	1
2017	1
2018	1
2019	1
2020	1
2022	1
2024	1

1

Chowdhury SR, Chuong P, Mgbemena VE, Statsyuk A. Chowdhury SR, et al. Among authors: mgbemena ve. bioRxiv [Preprint]. 2024 Jan 1:2023.12.30.573733. doi: 10.1101/2023.12.30.573733. bioRxiv. 2024. PMID: 38260247 Free PMC article. Preprint.

2

BRCA1 and TP53 codeficiency causes a PARP inhibitor-sensitive erythroproliferative neoplasm.

Lopez-Perez G, Wijayatunge R, McCrum KB, Holmstrom SR, Mgbemena VE, Ross TS. Lopez-Perez G, et al. Among authors: mgbemena ve. JCI Insight. 2022 Dec 22;7(24):e158257. doi: 10.1172/jci.insight.158257. JCI Insight. 2022. PMID: 36346676 Free PMC article.

3

Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia.

Ross TS, Mgbemena VE. Ross TS, et al. Among authors: mgbemena ve. Mol Cell Oncol. 2014 Oct 29;1(3):e963450. doi: 10.4161/23723548.2014.963450. eCollection 2014 Jul-Sep. Mol Cell Oncol. 2014. PMID: 27308345 Free PMC article. Review.

4

Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis.

Holmstrom SR, Wijayatunge R, McCrum K, Mgbemena VE, Ross TS. Holmstrom SR, et al. Among authors: mgbemena ve. iScience. 2019 Sep 27;19:809-820. doi: 10.1016/j.isci.2019.08.031. Epub 2019 Aug 26. iScience. 2019. PMID: 31499338 Free PMC article.

5

Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell Function.

Mgbemena VE, Signer RAJ, Wijayatunge R, Laxson T, Morrison SJ, Ross TS. Mgbemena VE, et al. Cell Rep. 2017 Jan 24;18(4):947-960. doi: 10.1016/j.celrep.2016.12.075. Cell Rep. 2017. PMID: 28122244 Free PMC article.

6

Deficiency of the Endocytic Protein Hip1 Leads to Decreased Gdpd3 Expression, Low Phosphocholine, and Kypholordosis.

Wijayatunge R, Holmstrom SR, Foley SB, Mgbemena VE, Bhargava V, Perez GL, McCrum K, Ross TS. Wijayatunge R, et al. Among authors: mgbemena ve. Mol Cell Biol. 2018 Nov 13;38(23):e00385-18. doi: 10.1128/MCB.00385-18. Print 2018 Dec 1. Mol Cell Biol. 2018. PMID: 30224518 Free PMC article.

7

Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells.

Philips ST, Hildenbrand ZL, Oravecz-Wilson KI, Foley SB, Mgbemena VE, Ross TS. Philips ST, et al. Among authors: mgbemena ve. Oncogene. 2014 Nov 13;33(46):5379-90. doi: 10.1038/onc.2013.484. Epub 2013 Nov 18. Oncogene. 2014. PMID: 24240679 Free PMC article.

8

Genomic Fabric Remodeling in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): A New Paradigm and Proposal for a Personalized Gene Therapy Approach.

Iacobas DA, Mgbemena VE, Iacobas S, Menezes KM, Wang H, Saganti PB. Iacobas DA, et al. Among authors: mgbemena ve. Cancers (Basel). 2020 Dec 8;12(12):3678. doi: 10.3390/cancers12123678. Cancers (Basel). 2020. PMID: 33302383 Free PMC article.

9

Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic.

Foley SB, Rios JJ, Mgbemena VE, Robinson LS, Hampel HL, Toland AE, Durham L, Ross TS. Foley SB, et al. Among authors: mgbemena ve. EBioMedicine. 2015 Jan;2(1):74-81. doi: 10.1016/j.ebiom.2014.12.003. EBioMedicine. 2015. PMID: 26023681 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year